Duke University begins universal flu vaccine trial
Duke University is leading a phase 1 trial of a universal flu vaccine that could provide longer and broader protection against seasonal and pandemic strains.
Stay updated with breaking news from Trials Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Duke University is leading a phase 1 trial of a universal flu vaccine that could provide longer and broader protection against seasonal and pandemic strains.
A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun.
A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun. The trial is testing the safety, tolerability and processing in the body of escalating doses of the investigational drug product HOPO 14-1 in healthy adults. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding the Phase 1 trial, which is sponsored and conducted by SRI International of Menlo Park, California.
A pioneering clinical trial of an experimental oral medication designed to eliminate radioactive contaminants from within the body has commenced. The
Reducing the dose and duration of radiotherapy treatments for anal cancer may result in fewer side effects, recent clinical trial results have shown.